日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

靶向 HIV gp160 的免疫缀合物的设计和体内表征

期刊:Journal of Virology
影响因子:3.8
doi:10.1128/JVI.01360-16
Pincus Seth H, Song Kejing, Maresh Grace A, Frank Anderson, Worthylake David, Chung Hye-Kyung, Polacino Patricia, Hamer Dean H, Coyne Cody P, Rosenblum Michael G, Marks John W, Chen Gang, Weiss Deborah, Ghetie Victor, Vitetta Ellen S, Robinson James E, Hu Shiu-Lok
免疫/内分泌
发表日期：2017
文献求助 收藏

Gemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549).

吉西他滨-(5'-磷酰胺)-[抗IGF-1R]：分子设计、合成有机化学反应以及在肺腺癌(A549)群体中的抗肿瘤细胞毒性效力

期刊:Chemical Biology & Drug Design
影响因子:3.3
doi:10.1111/cbdd.12845
Coyne Cody P, Narayanan Lakshmi
肿瘤
肺癌
发表日期：2017
文献求助 收藏

Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549)

地塞米松-(C21-磷酰胺)-[抗EGFR]：分子设计、合成有机化学反应及抗肺腺癌(A549)的抗肿瘤细胞毒性效力

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S102075
Coyne, Cody P; Narayanan, Lakshmi
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
肿瘤细胞
毒理研究
发表日期：2016
文献求助 收藏

Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate

利用紫外光活化蒽环类中间体合成共价表柔比星-(C(3)-酰胺)-抗HER2/neu免疫化疗药物

期刊:Cancer Biotherapy and Radiopharmaceuticals
影响因子:2.1
doi:10.1089/cbr.2011.1097
Coyne, Cody P; Jones, Toni; Bear, Ryan
HER2
免疫/内分泌
发表日期：2012
文献求助 收藏